BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12242076)

  • 21. T(h)2 cytokine dependence of IgD production by normal human B cells.
    Levan-Petit I; Lelievre E; Barra A; Limosin A; Gombert B; Preud'homme JL; Lecron JC
    Int Immunol; 1999 Nov; 11(11):1819-28. PubMed ID: 10545486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases.
    Watanabe M; Amino N; Hochito K; Watanabe K; Kuma K; Iwatani Y
    Thyroid; 1997 Oct; 7(5):743-7. PubMed ID: 9349577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of removing human Graves' thyroid xenografts after eight weeks in nude mice and rexenografting them into SCID mice.
    Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Akasu F; Miller N; Jamieson C; Volpé R
    J Clin Endocrinol Metab; 1994 Feb; 78(2):367-74. PubMed ID: 8106624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methimazole upregulates T-cell-derived cytokines without improving the existing Th1/Th2 imbalance in Graves' disease.
    Kocjan T; Wraber B; Kocijancic A; Hojker S
    J Endocrinol Invest; 2004 Apr; 27(4):302-7. PubMed ID: 15233546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
    Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
    Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD).
    Resetkova E; Arreaza G; Yoshikawa N; Morita T; Kim H; Carayon P; Volpé R
    Clin Exp Immunol; 1993 Mar; 91(3):397-403. PubMed ID: 8443962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1987 Nov; 65(5):922-8. PubMed ID: 2959679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methimazole therapy in Graves' disease influences the abnormal expression of CD69 (early activation antigen) on T cells.
    Corrales JJ; López A; Ciudad J; Mories MT; Miralles JM; Orfao A
    J Endocrinol; 1997 Dec; 155(3):491-500. PubMed ID: 9487994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic analyses and concanavalin-A-induced suppressor cell dysfunction of intrathyroidal lymphocytes from patients with Graves' disease.
    Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Matsunaga M; Tezuka H; Nakao H; Kawakami A; Izumi M
    J Clin Endocrinol Metab; 1988 Nov; 67(5):1018-24. PubMed ID: 2972737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of Epstein-Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individuals.
    Nagata K; Higaki K; Nakayama Y; Miyauchi H; Kiritani Y; Kanai K; Matsushita M; Iwasaki T; Sugihara H; Kuwamoto S; Kato M; Murakami I; Nanba E; Kimura H; Hayashi K
    Autoimmunity; 2014 May; 47(3):193-200. PubMed ID: 24467196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of adding a surfeit of autologous CD8+ T cells to SCID mice after secondary rexenografts of Graves' thyroid tissue.
    Mukuta T; Nishikawa M; Arreaza G; Resetkova E; Yoshikawa N; Fornasier V; Young E; Volpé R
    Thyroid; 1996 Oct; 6(5):429-36. PubMed ID: 8936667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.
    O'Sullivan ST; Lederer JA; Horgan AF; Chin DH; Mannick JA; Rodrick ML
    Ann Surg; 1995 Oct; 222(4):482-90; discussion 490-2. PubMed ID: 7574928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
    Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
    J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE.
    Saxon A; Ke Z; Bahati L; Stevens RH
    J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):333-44. PubMed ID: 1698844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
    Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
    Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of interleukins on EGF-stimulated growth promotion in human thyroid cells: differential modifications by IL-2 and IL-6 in Graves' and normal thyroid cells.
    Shimomura N; Itoh M; Okugawa T; Murata Y; Seo H
    Endocr Regul; 1994 Jun; 28(2):55-65. PubMed ID: 7949016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble forms of CD40 inhibit biologic responses of human B cells.
    Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
    J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
    Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
    Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of IL-13 in CD4 T cell-dependent IgE production in atopy.
    Levy F; Kristofic C; Heusser C; Brinkmann V
    Int Arch Allergy Immunol; 1997 Jan; 112(1):49-58. PubMed ID: 8980464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism.
    Ueki I; Abiru N; Kobayashi M; Nakahara M; Ichikawa T; Eguchi K; Nagayama Y
    Clin Exp Immunol; 2011 Mar; 163(3):309-17. PubMed ID: 21235532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.